News, Resources, & Updates

All
  • All
  • Articles
  • Calendar
  • Compliance
  • Newsletter
  • Position Statements
  • Press Release
  • Regulatory
  • Uncategorized
brtsh hpus

The British Homœopathic Pharmacopœia

By Eric Foxman, AAHP Secretary A quick look at its history, purpose, and contents, as well as the potential for adulteration and misbranding violations in...
recall

Prepare for Recalls: 5 Crucial Steps

By Ryan Gooley, Recall Consultant, Stericycle   Recalls impact thousands of companies every year, and they represent serious risk for the brands impacted. Homeopathic recalls,...

Homeopathic Industry Mourns John A. Borneman, III

John A. Borneman, III MILWAUKIE, Ore., July 13, 2018 — The American Association of Homeopathic Pharmacists (AAHP) mourns the loss of...

Health Care Product Recalls

By Mark Land, AAHP President July 1, 2018 Product recalls are an important tool for manufacturers and the Food and Drug Administration (FDA) to minimize...

Crystal Ball: 2018 Federal Election

By Pete Evich, AAHP government relations “It's tough to make predictions, especially about the future.” ― Yogi Berra With the mid-term federal elections almost five...
calenula officinalis

Calendula officinalis: A Clinical Snapshot

By Todd Hoover, MD July 1, 2018 Calendula officinalis has a long-standing history of traditional herbal use for skin irritations and infections. A tincture of...

Homeopathic Manufacturers Campaign Sends 38,000 Letters to Capitol Hill

MILWAUKIE, Ore., June 27, 2018 — As the result of the American Association of Homeopathic Pharmacists’ (AAHP) first grassroots effort, 38,000 letters from consumers and...

AAHP Rouses 38,000 Letters to Capitol Hill and Garners Congressional Support

As the result of the AAHP’s first grassroots effort, 38,000 letters from consumers and health care providers poured into offices of U.S. senators and representatives this spring....

How Much Can Machine Learning Help Us?

By Mark Land, AAHP President June 4, 2018 FDA docket 2017-D-6580 for comments on the draft guidance for FDA staff and industry entitled “Drug Products...